Differences in the ankle-brachial index in the general population after 4 years of follow-up

被引:6
作者
Lahoz, Carlos [1 ]
Garcia-Fernandez, Teresa [2 ]
Barrionuevo, Maria [2 ]
Vicente, Ignacio [2 ]
Gonzalez-Alegre, Teresa [1 ]
Maria Mostaza, Jose [1 ]
机构
[1] Hosp Carlos III, Madrid 28029, Spain
[2] Ctr Salud Fuencarral, Madrid, Spain
关键词
Ankle-brachial index; atherogenic dyslipidaemia; blockers of the renin-angiotensin system; PERIPHERAL ARTERIAL-DISEASE; CARDIOVASCULAR HEALTH; ARM INDEX; RISK-FACTORS; MORTALITY; EVENTS; PROGRESSION; RAMIPRIL; ATHEROSCLEROSIS; CHOLESTEROL;
D O I
10.1024/0301-1526/a000254
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Variation in the ankle-brachial index (ABI) is related to the progression of atherosclerosis in the lower extremities and is associated with mid-term cardiovascular morbidity and mortality. The aim of this study was to investigate the changes in ABI after four years of follow-up of individuals in the general population, and the factors associated with relevant variations observed. Patients and methods: The study was performed in 750 volunteers (mean age 69.9 years) men without any evidence of peripheral artery disease, who attended a primary care centre. A complete physical examination, together with standard blood tests and ABI were performed. Four years later a new clinical evaluation was done. Variations in ABI values were considered relevant if > 10 %. Results: Mean ABI in the second visit was 1.07 +/- 0.15, which represented 0.02 +/- 0.12 points lower than in the first visit (P < 0.001). Of these subjects, 157 (21.6%) had an ABI decrease > 10 %. Multivariate analysis showed that the change was associated with male gender, cardiovascular history, no intake of blockers of the renin-angiotensin system, and the presence of atherogenic dyslipidaemia. A relevant increase in ABI was observed in 117 subjects (16.1 %), but was not associated with any of the studied factors. Conclusions: ABI values tend to decrease in the general population, although one sixth of the studied subjects had a relevant increase in this parameter.
引用
收藏
页码:112 / 119
页数:8
相关论文
共 30 条
  • [1] Risk factors for progression of peripheral arterial disease in large and small vessels
    Aboyans, Victor
    Criqui, Michael H.
    Denenberg, Julie O.
    Knoke, James D.
    Ridker, Paul M.
    Fronek, Arnost
    [J]. CIRCULATION, 2006, 113 (22) : 2623 - 2629
  • [2] RETRACTED: Brief communication: Ramipril markedly improves walking ability in patients with peripheral arterial disease - A randomized trial (Retracted article)
    Ahimastos, AA
    Lawler, A
    Reid, CM
    Blombery, PA
    Kingwell, BA
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 144 (09) : 660 - 664
  • [3] Ethnicity and risk factors for change in the ankle-brachial index: The Multi-Ethnic Study of Atherosclerosis
    Allison, Matthew A.
    Cushman, Mary
    Solomon, Cam
    Aboyans, Victor
    McDermott, Mary M.
    Goff, David C., Jr.
    Criqui, Michael H.
    [J]. JOURNAL OF VASCULAR SURGERY, 2009, 50 (05) : 1049 - 1056
  • [4] [Anonymous], 2001, JAMA, V285, P2486
  • [5] Natural history of claudication: Long-term serial follow-up study of 1244 claudicants
    Aquino, R
    Johnnides, C
    Makaroun, M
    Whittle, JC
    Muluk, VS
    Kelley, ME
    Muluk, SC
    [J]. JOURNAL OF VASCULAR SURGERY, 2001, 34 (06) : 962 - 968
  • [6] Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S
    Ballantyne, CM
    Olsson, AG
    Cook, TJ
    Mercuri, MF
    Pedersen, TR
    Kjekshus, J
    [J]. CIRCULATION, 2001, 104 (25) : 3046 - 3051
  • [7] Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing
    Bird, CE
    Criqui, MH
    Fronek, A
    Denenberg, JO
    Klauber, MR
    Langer, RD
    [J]. VASCULAR MEDICINE, 1999, 4 (01) : 15 - 21
  • [8] Lipoprotein management in patients with cardiometabolic risk
    Brunzell, John D.
    Davidson, Michael
    Furberg, Curt D.
    Goldberg, Ronald B.
    Howard, Barbara V.
    Stein, James H.
    Witztum, Joseph L.
    [J]. DIABETES CARE, 2008, 31 (04) : 811 - 822
  • [9] Peripheral artery disease: potential role of ACE-inhibitor therapy
    Coppola, Giuseppe
    Romano, Giuseppe
    Corrado, Egle
    Grisanti, Rosa Maria
    Novo, Salvatore
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (06) : 1179 - 1187
  • [10] Progression of Peripheral Arterial Disease Predicts Cardiovascular Disease Morbidity and Mortality
    Criqui, Michael H.
    Ninomiya, John K.
    Wingard, Deborah L.
    Ji, Ming
    Fronek, Arnost
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (21) : 1736 - 1742